PULMONX CORPORATION APIC, Share-based Payment Arrangement, Increase for Cost Recognition
PULMONX CORPORATION (LUNG) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $3.63 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-04
- PULMONX CORPORATION apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $3.63M, a 40.74% decline year-over-year.
- PULMONX CORPORATION apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $4.14M, a 25.37% decline year-over-year.
- PULMONX CORPORATION apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $5.09M, a 13.15% decline year-over-year.
- PULMONX CORPORATION apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $6.13M, a 2.58% increase year-over-year.
- PULMONX CORPORATION apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $21.06M, a 8.26% decline from fiscal 2024.
- PULMONX CORPORATION apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $22.96M, a 2.29% increase from fiscal 2023.
- PULMONX CORPORATION apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $22.44M, a 31.84% increase from fiscal 2022.
- PULMONX CORPORATION apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $17.02M, a 54.74% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.63M 10-Q · filed 2026-08-04 | $7.78M derived: sum of 2 quarters · filed 2026-08-04 | ||
| 2026-03-31 | $4.14M 10-Q · filed 2026-08-04 | |||
| 2025-12-31 | $21.06M 10-K · filed 2026-03-10 | |||
| 2025-09-30 | $5.09M 10-Q · filed 2025-11-12 | $11.23M derived: sum of 2 quarters · filed 2026-08-04 | $16.78M derived: sum of 3 quarters · filed 2026-08-04 | |
| 2025-06-30 | $6.13M 10-Q · filed 2026-08-04 | $11.69M derived: sum of 2 quarters · filed 2026-08-04 | ||
| 2025-03-31 | $5.55M 10-Q · filed 2026-08-04 | |||
| 2024-12-31 | $22.96M 10-K · filed 2026-03-10 | |||
| 2024-09-30 | $5.86M 10-Q · filed 2025-11-12 | $11.84M derived: sum of 2 quarters · filed 2025-11-12 | $17.59M derived: sum of 3 quarters · filed 2025-11-12 | |
| 2024-06-30 | $5.98M 10-Q · filed 2025-11-12 | $11.72M derived: sum of 2 quarters · filed 2025-11-12 | ||
| 2024-03-31 | $5.74M 10-Q · filed 2025-11-12 | |||
| 2023-12-31 | $22.44M 10-K · filed 2025-02-25 | |||
| 2023-09-30 | $6.10M 10-Q · filed 2024-11-01 | $11.99M derived: sum of 2 quarters · filed 2024-11-01 | $16.75M derived: sum of 3 quarters · filed 2024-11-01 | |
| 2023-06-30 | $5.89M 10-Q · filed 2024-11-01 | $10.65M derived: sum of 2 quarters · filed 2024-11-01 | ||
| 2023-03-31 | $4.76M 10-Q · filed 2024-11-01 | |||
| 2022-12-31 | $17.02M 10-K · filed 2024-02-27 | |||
| 2022-09-30 | $4.47M 10-Q · filed 2023-11-03 | $9.02M derived: sum of 2 quarters · filed 2023-11-03 | $12.64M derived: sum of 3 quarters · filed 2023-11-03 | |
| 2022-06-30 | $4.55M 10-Q · filed 2023-11-03 | $8.17M derived: sum of 2 quarters · filed 2023-11-03 | ||
| 2022-03-31 | $3.62M 10-Q · filed 2023-11-03 | |||
| 2021-12-31 | $11.00M 10-K · filed 2023-03-01 | |||
| 2021-09-30 | $3.04M 10-Q · filed 2022-11-08 | $5.51M derived: sum of 2 quarters · filed 2022-11-08 | $7.97M derived: sum of 3 quarters · filed 2022-11-08 | |
| 2021-06-30 | $2.48M 10-Q · filed 2022-11-08 | $4.94M derived: sum of 2 quarters · filed 2022-11-08 | ||
| 2021-03-31 | $2.46M 10-Q · filed 2022-11-08 | |||
| 2020-12-31 | $3.49M 10-K · filed 2022-03-01 | |||
| 2020-09-30 | $518.00K 10-Q · filed 2021-11-09 | $677.00K derived: sum of 2 quarters · filed 2021-11-09 | $886.00K derived: sum of 3 quarters · filed 2021-11-09 | |
| 2020-06-30 | $159.00K 10-Q · filed 2021-11-09 | $368.00K derived: sum of 2 quarters · filed 2021-11-09 | ||
| 2020-03-31 | $209.00K 10-Q · filed 2021-11-09 | |||
| 2019-12-31 | $364.00K 10-K · filed 2021-03-15 | |||
| 2019-09-30 | $72.00K 10-Q · filed 2020-11-13 | $147.00K derived: sum of 2 quarters · filed 2020-11-13 | $197.00K derived: sum of 3 quarters · filed 2020-11-13 | |
| 2019-06-30 | $75.00K 10-Q · filed 2020-11-13 | $125.00K derived: sum of 2 quarters · filed 2020-11-13 | ||
| 2019-03-31 | $50.00K 10-Q · filed 2020-11-13 | |||
| 2018-12-31 | $366.00K 10-K · filed 2021-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |